British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said Monday ...

While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...

With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities ...

ESET Research remains at the core of our efforts, informing not only the prevention-enhancing capabilities and R&D of our products (such as ESET Threat Intelligence), but also providing a better ...

Archer’s Midnight aircraft nears production, targeting FAA approval by 2025 for passenger flights. Click here to read my most recent analysis of ACHR.